Rumalaya Forte (tablet)
Total no. of papers:9 - Clinical Papers:9
(Research papers based on Indications)
Osteoarthritis
- Evaluation of the comparative clinical efficacy and safety of Rumalaya forte and "Glucosamine and chondroitincombination
Srivastava, R.N., Sharma, V.D., Ashish Mahendra, Department of Orthopedics, K.G. Medical University, Lucknow, India and Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bengaluru, India. Medicine Update (2005): (12), 12, 43.
- Evaluation and Comparative Clinical Efficacy and Safety of Rumalaya Forte in Patients Suffering from Osteoarthritis of the Knee
Nirbhay Srivastava*, R Sadh**, BK Jain**, SA Kolhapure***
Head,Department of Orthopedic Surgery & Traumatology, Gandhi Medical College & Associated Hospital, Bhopal, India. **Department of Orthopedic Surgery & Traumatology, Gandhi Medical College & Associated Hospital, Bhopal, India. ***Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bengaluru, India. Indian Journal of Clinical Practice July 2005.
- Evaluation of the efficacy and safety of JT-2000 in osteoarthritis: A comparative clinical trial
Hemant H. Mathur, Department of Orthopedics, Ashish Khurana, Divya Mathur, Medical College & S. S. G. Hospital, Vadodara, Gujarath, and Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bengaluru, India, Medicine Update (2004): 11 (9), 31-37. - Evaluation of the efficacy and safety of JT-2000 (Rumalaya forte) in osteoarthritis
Khare, K.D., Rahul Khare, Department of Orthopedics, Era's Lucknow Medical College, Lucknow, Uttar Pradesh, India, and Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bengaluru, Karnataka, India, Indian Journal of Clinical Practice (2004): (14), 10, 42. - Clinical evaluation of the efficacy of JT-2000 (Rumalaya forte) in the management of osteoarthritis: A double-blind placebo-controlled trial
Upadhyay, L., Tripathi, K., Department of medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India, and Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bengaluru, Karnataka, India, Medicine Update (2004): (11), 10, 31. - Clinical evaluation of Rumalaya forte in osteoarthrosis
Chandanwale, A.S., M.D., Professor & Head, Department of Orthopedics, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India, and Kala Suhas Kulkarni M.D., Medical Advisor, R&D Center, The Himalaya Drug Company, Makali, Bengaluru, India, Medicine Update (2003): (10), 9, 23-26. - Evaluating the safety and efficacy of Rumalaya forte: A double-blind clinical trial
Rastogi, S., Sivaraman, S.T., Department of Orthopedics, All Indian Institute of Medical Sciences, New Delhi, India, and Kala Suhas Kulkarni, R&D Center, The Himalaya Drug Company, Bengaluru, India, Orthopaedics Today (2003): (V), 1, 63-65. - EFFECT OF POLYHERBAL FORMULATION RUMALAYA FORTE ON ADJUVANT INDUCED ARTHRITIS IN RATS
Subash K. R.*, Cheriyan B. V., Parvathavarthini S., Bhaarati G. M. and Venugopal V.
*Department of Pharmacology, Meenakshi Medical College & Research Institute, MAHER (Meenakshi University), Kanchipuram–631552, Chennai, Tamil Nadu.
INDIAN DRUGS 49(10) OCTOber 2012
Lumbar Spondylosis
- Evaluation of the clinical efficacy and long-term safety of Rumalaya forte tablets and Rumalaya liniment in patients suffering from lumbago associated with lumbar arthrosis (spondylosis): An open study.
Hemant H Mathur, Dipender Chaudhary, Department of Orthopaedics, Divya Mathur, Department of Anesthesiology, Govt. Medical College and SSG Hospital, Vadodara, India, and Pralhad S. Patki, S.K. Mitra, R&D Center, The Himalaya Drug Company, Bengaluru, India. Indian Medical Journal 2009; 103(2): 57.